Utah Medical Products Inc
UTMD56.610USD
+0.010+0.02%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
181.38MMarket Cap
15.98P/E TTM
More Details of Utah Medical Products Inc Company
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Utah Medical Products Inc Info
Ticker SymbolUTMD
Company nameUtah Medical Products Inc
IPO dateDec 01, 1982
CEOCornwell (Kevin L)
Number of employees155
Security typeOrdinary Share
Fiscal year-endDec 01
Address7043 S 300 West
CityMIDVALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code84070
Phone18015215301
Websitehttp://www.utahmed.com
Ticker SymbolUTMD
IPO dateDec 01, 1982
CEOCornwell (Kevin L)
Company Executives of Utah Medical Products Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Gynecology/Electrosurgery/Urology
4.81M
48.30%
Neonatal
2.10M
21.12%
Blood Pressure Monitoring and Accessories
2.02M
20.29%
Obstetrics
1.02M
10.30%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Gynecology/Electrosurgery/Urology
4.81M
48.30%
Neonatal
2.10M
21.12%
Blood Pressure Monitoring and Accessories
2.02M
20.29%
Obstetrics
1.02M
10.30%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
Other
65.57%
Shareholders
Shareholders
Proportion
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
Other
65.57%
Shareholder Types
Shareholders
Proportion
Investment Advisor
41.26%
Investment Advisor/Hedge Fund
19.06%
Hedge Fund
8.74%
Individual Investor
7.14%
Research Firm
0.70%
Bank and Trust
0.18%
Pension Fund
0.05%
Insurance Company
0.04%
Other
22.83%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
243
2.27M
70.80%
-636.90K
2025Q2
249
2.53M
77.79%
-699.23K
2025Q1
251
2.54M
78.08%
-658.65K
2024Q4
245
2.63M
77.47%
-634.89K
2024Q3
233
2.73M
78.80%
-558.16K
2024Q2
224
2.74M
78.05%
-528.35K
2024Q1
214
2.81M
78.59%
-191.73K
2023Q4
203
2.83M
78.07%
-204.85K
2023Q3
194
2.97M
81.82%
-7.55K
2023Q2
183
2.95M
81.20%
-24.79K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Brandes Investment Partners, L.P.
333.20K
10.39%
+61.88K
+22.81%
Aug 31, 2025
Renaissance Technologies LLC
213.31K
6.65%
-4.40K
-2.02%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
197.47K
6.16%
+4.51K
+2.34%
Jun 30, 2025
Cornwell (Kevin L)
188.47K
5.88%
--
--
Mar 03, 2025
The Vanguard Group, Inc.
177.10K
5.52%
+730.00
+0.41%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
157.93K
4.93%
+12.53K
+8.61%
Jun 30, 2025
Hotchkis and Wiley Capital Management, LLC
111.95K
3.49%
+10.31K
+10.14%
Jun 30, 2025
Minerva Advisors LLC
93.06K
2.9%
+6.16K
+7.08%
Jun 30, 2025
Geode Capital Management, L.L.C.
114.82K
3.58%
+7.04K
+6.53%
Jun 30, 2025
State Street Investment Management (US)
70.12K
2.19%
-10.03K
-12.51%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Acquirers Small and Micro Deep Value ETF
0.89%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
Royce Quant Small-Cap Quality Value ETF
0.2%
WisdomTree U.S. SmallCap Dividend Fund
0.06%
iShares Micro-Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Global X Russell 2000 ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
View more
Acquirers Small and Micro Deep Value ETF
Proportion0.89%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.21%
Royce Quant Small-Cap Quality Value ETF
Proportion0.2%
WisdomTree U.S. SmallCap Dividend Fund
Proportion0.06%
iShares Micro-Cap ETF
Proportion0.03%
Avantis US Small Cap Equity ETF
Proportion0.02%
Global X Russell 2000 ETF
Proportion0.01%
DFA Dimensional US Small Cap Value ETF
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Dividend
A total of
27.29M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jul 29, 2025
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Oct 02, 2025 going ex on Sep 17, 2025
Sep 17, 2025
Oct 02, 2025
Sep 17, 2025
May 08, 2025
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jul 03, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jul 03, 2025
Jun 16, 2025
Feb 04, 2025
UTMD.NB Final Cash Dividend of gross USD 0.305 paid on Apr 03, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 03, 2025
Mar 14, 2025
Dec 11, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jan 03, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 03, 2025
Dec 16, 2024
Aug 02, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Oct 04, 2024 going ex on Sep 20, 2024
Sep 20, 2024
Oct 04, 2024
Sep 20, 2024
May 07, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 06, 2024
UTMD.NB Final Cash Dividend of gross USD 0.3 paid on Apr 03, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 03, 2024
Mar 14, 2024
Oct 31, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 03, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 03, 2024
Dec 14, 2023
Aug 02, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Oct 03, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 03, 2023
Sep 14, 2023
May 10, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Jul 06, 2023 going ex on Jun 15, 2023
Jun 16, 2023
Jul 06, 2023
Jun 15, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Utah Medical Products Inc?
The top five shareholders of Utah Medical Products Inc are:
Brandes Investment Partners, L.P. holds 333.20K shares, accounting for 10.39% of the total shares.
Renaissance Technologies LLC holds 213.31K shares, accounting for 6.65% of the total shares.
Dimensional Fund Advisors, L.P. holds 197.47K shares, accounting for 6.16% of the total shares.
Cornwell (Kevin L) holds 188.47K shares, accounting for 5.88% of the total shares.
The Vanguard Group, Inc. holds 177.10K shares, accounting for 5.52% of the total shares.
Brandes Investment Partners, L.P. holds 333.20K shares, accounting for 10.39% of the total shares.
Renaissance Technologies LLC holds 213.31K shares, accounting for 6.65% of the total shares.
Dimensional Fund Advisors, L.P. holds 197.47K shares, accounting for 6.16% of the total shares.
Cornwell (Kevin L) holds 188.47K shares, accounting for 5.88% of the total shares.
The Vanguard Group, Inc. holds 177.10K shares, accounting for 5.52% of the total shares.
What are the top three shareholder types of Utah Medical Products Inc?
The top three shareholder types of Utah Medical Products Inc are:
Brandes Investment Partners, L.P.
Renaissance Technologies LLC
Dimensional Fund Advisors, L.P.
Brandes Investment Partners, L.P.
Renaissance Technologies LLC
Dimensional Fund Advisors, L.P.
How many institutions hold shares of Utah Medical Products Inc (UTMD)?
As of 2025Q3, 243 institutions hold shares of Utah Medical Products Inc, with a combined market value of approximately 2.27M, accounting for 70.80% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -6.99%.
What is the biggest source of revenue for Utah Medical Products Inc?
In FY2025Q2, the Gynecology/Electrosurgery/Urology business generated the highest revenue for Utah Medical Products Inc, amounting to 4.81M and accounting for 48.30% of total revenue.
